Key result
Natriuretic peptide-guided management using BNP and NT-proBNP provides valuable diagnostic and prognostic information to optimize therapy for acutely destabilized heart failure.
Why the study?
Does natriuretic peptide-guided treatment improve clinical outcomes in patients with acutely destabilized heart failure?
Does natriuretic peptide-guided treatment improve clinical outcomes in patients with acutely destabilized heart failure?
BNP and NT-proBNP are valuable tools for guiding the management and therapy optimization of acutely destabilized heart failure.
No takes yet. Share an insight, caveat, or question.
May inform acute HF therapy optimization; leaves open impact on clinical outcomes.
Bhardwaj et al. (2009) conducted a review in Acutely destabilized heart failure. Natriuretic peptide-guided management (BNP/NT-proBNP) was evaluated. Natriuretic peptide-guided management using BNP and NT-proBNP provides valuable diagnostic and prognostic information to optimize therapy for acutely destabilized heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: